Milestone Pharmaceuticals

$6.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.20 (-2.98%) Today
$0.00 (0.00%) As of 4:00 PM EST after-hours

Why Robinhood?

You can buy or sell MIST and other stocks, options, and ETFs commission-free!

About MIST

Milestone Pharmaceuticals Inc. Common Shares, also called Milestone Pharmaceuticals, is a biopharmaceutical company. It engages in the development and commercialization of novel small molecule therapeutics based on clinically-validated mechanisms for the treatment of cardiovascular diseases. The firm designs and develops a rapid-onset nasal spray with Etripamil. The company was founded by Philippe Douville and Philippe Lamarre in 2005 and is headquartered in Montreal, Canada. The listed name for MIST is Milestone Pharmaceuticals Inc. Common Shares.

CEO
Joseph G. Oliveto
Employees
30
Headquarters
Montréal, Québec
Founded
2005
Market Cap
194.15M
Price-Earnings Ratio
Dividend Yield
Average Volume
102.09K
High Today
$6.69
Low Today
$6.49
Open Price
$6.57
Volume
64.26K
52 Week High
$23.25
52 Week Low
$1.69

Collections

MIST Earnings

-$1.04
-$0.69
-$0.35
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
-$0.40 per share

You May Also Like